Outcome of operative therapy of hepatic metastatic stomach carcinoma: A retrospective analysis

World Journal of Surgery

Volumn 36, Issue 4, 2012, Pages 872-878

  Schildberg, Claus W ^a   Croner, R ^a   Merkel, S ^a   Schellerer, V ^a   Muller V ^a   Yedibela, S ^a   Hohenberger, W ^a   Peros, G ^a   Perrakis, A ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; FEMALE; HUMAN; KAPLAN MEIER METHOD; LIVER RESECTION; LIVER TUMOR; MALE; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; REGISTER; RETROSPECTIVE STUDY; STOMACH TUMOR;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEPATECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; REGISTRIES; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 84863718863     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-012-1492-5     Document Type: Article

References (32)

1. Al-Batran SE, Hartmann J, Probst S, Arbeitsgemeinschaft Internistische Onkologie et al (2008) Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie. J Clin Oncol 26:1435-1442
2. Schmiegel W, Reinacher-Schick A, Arnold D et al (2008) Update S3-guideline "colorectal cancer" 2008. Z Gastroenterol 46:799-840 [in German]
3. Ojima H, Ootake S, Yokobori T et al (2007) Treatment of multiple liver metastasis from gastric carcinoma. World J Surg Oncol 5:70
4. Kutlu R, Sarac K, Yilmaz S et al (2005) Percutaneous right portal vein embolization with polyvinyl alcohol particles in gastric cancer metastasis: report of a case. Surg Today 35:765-769
5. Scheele J, Altendorf-Hofmann A, Grube T (2001) Resection of colorectal liver metastases: which prognostic factors should govern patient selection? Chirurg 72:547-560
6. Choti MA, Sitzmann JV, Tiburi MF et al (2002) Trends in longterm survival following liver resection for hepatic colorectal metastases. Ann Surg 235:759-766
7. Fong Y, Cohen AM, Fortner JG et al (1997) Liver resection for colorectal metastases. J Clin Oncol 15:938-946
8. Goldsmith NA, Woodburne RT (1957) The surgical anatomy pertaining to liver resection. Surg Gynecol Obstet 105:310-318
9. Makino H, Kunisaki C, Izumisawa Y et al (2010) Indication for hepatic resection in the treatment of liver metastasis from gastric cancer. Anticancer Res 30:2367-2376
10. Yedibela S, Göhl J, Graz V et al (2005) Changes in indication and results after resection of hepatic metastases from noncolorectal primary tumors: a single-institutional review. Ann Surg Oncol 12:778-785
11. Laurent C, Rullier E, Feyler A et al (2001) Resection of noncolorectal and nonneuroendocrine liver metastases: late metastases are the only chance of cure. World J Surg 25:1532-1536. doi: 10.1007/s00268-001-0164-7
12. Lindell G, Ohlsson B, Saarella A et al (1998) Liver resection of noncolorectal secondaries. J Surg Oncol 69:66-70
13. Maksan SM, Lehnert T, Bastert G et al (2000) Curative liver resection for metastatic breast cancer. Eur J Surg Oncol 26: 209-212
14. Sakamoto Y, Ohyama S, Yamamoto J et al (2003) Surgical resection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients. Surgery 133:507-511
15. Van Ruth S, Mutsaerts E, Zoetmulder FAN et al (2001) Metastasectomy for liver metastases of non-colorectal primaries. Eur J Surg Oncol 27:662-667
16. Elias D, Cavalcanti de Albuqueque A, Eggenspieler P et al (1998) Resection of liver metastases from a noncolorectal primary: indications and results based on 147 monocentric patients. J Am Coll Surg 187:487-493
17. Harrison LE, Brennan MF, Newman E et al (1997) Hepatic resection for noncolorectal, nonneuroendocrine metastases: a fifteen-year experience with ninety-six patients. Surgery 121: 625-632
18. Okano K, Maeba T, Ishimura K et al (2002) Hepatic resection for metastatic tumors from gastric cancer. Ann Surg 235:86-91
19. Ambiru S, Miyazaki M, Ito H et al (2001) Benefits and limits of hepatic resection for gastric metastases. Am J Surg 181:279-283
20. Hwang SE, Yang DH, Kim CY et al (2009) Prognostic factors for survival in patients with hepatic recurrence after curative resection of gastric cancer. World J Surg 33:1468-1472. doi:10.1007/s00268-009-0034-2
21. Adam R, Chiche L, Aloia T et al (2006) Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model. Ann Surg 244: 524-535
22. Kakeji Y, Morita M, Maehara Y et al (2010) Strategies for treating liver metastasis from gastric cancer. Surg Today 40: 287-294
23. Cheon SH, Rha SY, Jeung HC et al (2008) Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases. Ann Oncol 19:1146-1153
24. Tsujimoto H, Ichikura T, Ono S et al (2010) Outcomes for patients following hepatic resection of metastatic tumors from gastric cancer. Hepatol Int 4:406-413
25. Tiberio GA, Coniglio A, Marchet A et al (2009) Metachronous hepatic metastases from gastric carcinoma: a multicentric survey. Eur J Surg Oncol 35:486-491
26. Chau I, Norman A, Cunningham D et al (2004) Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer - pooled analysis from three multicenter, randomized, controlled trials using individual patient data. J Clin Oncol 22:2395-2403
27. Zacherl J, Zacherl M, Scheuba C et al (2002) Analysis of hepatic resection of metastasis originating from gastric adenocarcinoma. J Gastrointest Surg 6:682-689
28. Choi SB, Song J, Kang CM et al (2010) Surgical outcome of metachronous hepatic metastases secondary to gastric cancer. Hepatogastroenterology 57:29-34
29. Van Cutsem E, Moiseyenko VM, Tjulandin S et al (2006) V325 Study Group Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group. J Clin Oncol 24:4991-4997
30. Nishiyama M, Wada S (2009) Docetaxel: its role in current and future treatments for advanced gastric Cancer. Gastric Cancer 12:132-141
31. Al-Batran SE, Hartmann JT, Hofheinz R et al (2008) Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie. Ann Oncol 19:1882-1887
32. Vecchione L, Orditura M, Ciardiello F et al (2009) Novel investigational drugs for gastric cancer. Expert Opin Investig Drugs 18:945-955